Editorial Perspectives On Data Management & Analysis

  1. Clinical Trials Enter A New Digital Era 11/17/2021

    The life sciences industry has been undergoing a transformation. Its seen advancements in how therapies are developed and improvements in how the industry works together. One development that has helped the industry evolve is the shift to digital technologies.

  2. How Real-World Data Will Advance Oncology Clinical Trials 10/28/2021

    Real-world data (RWD) is coming to fruition in clinical trials. One area where it is expected to have a huge impact on innovation is oncology studies. This topic was discussed by a panel of experts at The Future of Health Data conference hosted by Datavant.

  3. Data Liquidity: Privacy, Ethics, And Patient Benefit 10/26/2021

    There has been a push in recent years to increase the liquidity of patient data and make that data more accessible to the patients from whom it was gathered. But increasing the liquidity of data also increases concerns around privacy and ethics.

  4. Can Smarter Study Design Relieve The Recruitment Challenge? 9/18/2021

    Recruitment has always been a challenge for companies conducting clinical trials. Sponsor companies seeking new ways to engage and recruit patients have seen varied success. But could that challenge be mitigated or eliminated with smarter study design?

  5. How Otsuka Uses Decentralized Trials & Real-World Evidence 8/3/2021

    Prior to joining Otsuka in 2019, Christoph Koenen spent two years with GSK, 10 years with Novo Nordisk, and eight years with BMS. I recently spoke to him about some of the key lessons he’s learned over the years and how Otsuka is applying new clinical trial strategies and technologies, especially for the treatment of patients in mental health trials.

  6. Is AI Improving Outcomes In Clinical Trials? 1/21/2021

    In October 2020, I hosted a webinar on the topic of AI and how it will improve outcomes in clinical trials. This article highlights some of the comments from that discussion.

  7. A New Technology Takes Alkermes Into Oncology 10/6/2020

    Moving into a new therapeutic area is a difficult proposition for most companies. That is not news to Blair Jackson. Jackson, the SVP of corporate planning at Alkermes, has been with the company for more than 21 years and knows the challenges of moving into research on new diseases.

  8. Pharma's Investment In RWE Is Beginning To Pay Off 7/7/2020

    For years the life sciences industry has heard about the benefits of investing in real-world evidence (RWE) and real-world data (RWD). According to a recent report from Deloitte, that investment may finally be paying off for companies that climbed onboard and have been building those capabilities.

  9. Teva Develops First FDA-Approved Digitally-Integrated Inhaler 1/8/2020

    Two challenges have plagued asthma sufferers and researchers for year. The first is patients not adhering to their maintenance medication. The other is patients not using proper inhaler technique. A new digitally-integrated inhaler from Teva hopes to eliminate both problems.

  10. BMS-Pfizer Alliance Evaluates AFib Screening And Stroke Connection 12/10/2019

    In November 2019, the BMS-Pfizer Alliance announced the initiation of a new randomized, controlled study called GUARD-AF. The trial will evaluate whether atrial fibrillation (AFib) screening can ultimately impact the rate of stroke, compared to standard medical care in older individuals in a real-world setting.